A multicenter phase II single arm trial of isatuximab in patients with high risk smoldering multiple myeloma (HRSMM) Meeting Abstract

  

Authors:	Manasanch, E. E.; Jagannath, S.; Lee, H. C.; Patel, K. K.; Graham, C.; Kaufman, G. P.; Thomas, S. K.; Iyer, S.; Mailankody, S.; Korde, N.; Amini, B.; Lin, P.; Berkova, Z.; Weber, D. M.; Lei, F.; Lendvai, N.; Hildebrandt, M.; Neelapu, S. S.; Orlowski, R. Z.; Landgren, O.
Abstract Title:	A multicenter phase II single arm trial of isatuximab in patients with high risk smoldering multiple myeloma (HRSMM)
Meeting Title:	61st Annual Meeting and Exposition of the American Society of Hematology (ASH)
Journal Title:	Blood
Volume:	134
Issue:	Suppl. 1
Meeting Dates:	2019 Dec 7-10
Meeting Location:	Orlando, FL
ISSN:	0006-4971
Publisher:	American Society of Hematology
Date Published:	2019-11-13
Language:	English
ACCESSION:	WOS:000577160407241
DOI:	10.1182/blood-2019-123205
PROVIDER:	wos
Notes:	Meeting Abstract: 3116 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/175708